000			02125 a2200625 4500
005			20250514162122.0
264		0	_c20040702
008			200407s 0 0 eng d
022			_a0305-7453
024	7		_a10.1093/jac/dkg477 _2doi
040			_aNLM _beng _cNLM
100	1		_aPandey, Rajesh
245	0	0	_aPoly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. _h[electronic resource]
260			_bThe Journal of antimicrobial chemotherapy _cDec 2003
300			_a981-6 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdministration, Inhalation
650	0	4	_aAerosols
650	0	4	_aAnimals
650	0	4	_aAntibiotics, Antitubercular _xadministration & dosage
650	0	4	_aAntitubercular Agents _xadministration & dosage
650	0	4	_aArea Under Curve
650	0	4	_aBiological Availability
650	0	4	_aChemical Phenomena
650	0	4	_aChemical and Drug Induced Liver Injury _xpathology
650	0	4	_aChemistry, Physical
650	0	4	_aColony Count, Microbial
650	0	4	_aDrug Carriers
650	0	4	_aDrug Combinations
650	0	4	_aDrug Compounding
650	0	4	_aFemale
650	0	4	_aGuinea Pigs
650	0	4	_aHalf-Life
650	0	4	_aInjections, Intravenous
650	0	4	_aIsoniazid _xadministration & dosage
650	0	4	_aLactic Acid
650	0	4	_aLung _xmetabolism
650	0	4	_aMale
650	0	4	_aMicrospheres
650	0	4	_aMycobacterium tuberculosis _xdrug effects
650	0	4	_aParticle Size
650	0	4	_aPolyglycolic Acid
650	0	4	_aPolylactic Acid-Polyglycolic Acid Copolymer
650	0	4	_aPolymers
650	0	4	_aPyrazinamide _xadministration & dosage
650	0	4	_aRifampin _xadministration & dosage
650	0	4	_aTuberculosis _xdrug therapy
700	1		_aSharma, Anjali
700	1		_aZahoor, A
700	1		_aSharma, Sadhna
700	1		_aKhuller, G K
700	1		_aPrasad, B
773	0		_tThe Journal of antimicrobial chemotherapy _gvol. 52 _gno. 6 _gp. 981-6
856	4	0	_uhttps://doi.org/10.1093/jac/dkg477 _zAvailable from publisher's website
999			_c14351159 _d14351159